Editors
2
Impact
Loading...
3,548 views
2 citations
2,489 views
3 citations
Mini Review
29 March 2023

The development of graft versus host disease (GVHD) represents a long-standing complication of allogeneic hematopoietic cell transplantation (allo-HCT). Different approaches have been used to control the development of GVHD with most relying on variations of chemotherapy drugs to eliminate allo-reactive T cells. While these approaches have proven effective, it is generally accepted that safer, and less toxic GVHD prophylaxis drugs are required to reduce the health burden placed on allo-HCT recipients. In this review, we will summarize the emerging concepts revolving around three biologic-based therapies for GVHD using T regulatory cells (Tregs), myeloid-derived-suppressor-cells (MDSCs) and mesenchymal stromal cell (MSC) exosomes. This review will highlight how each specific modality is unique in its mechanism of action, but also share a common theme in their ability to preferentially activate and expand Treg populations in vivo. As these three GVHD prevention/treatment modalities continue their path toward clinical application, it is imperative the field understand both the biological advantages and disadvantages of each approach.

3,751 views
6 citations
Review
09 March 2023
Impact of oral microbiota on pathophysiology of GVHD
Akira Yamamoto
1 more and 
Hideaki Fujiwara

Allogeneic transplantation of hematopoietic cells is the only curative therapy for several hematopoietic disease in which patients receive cytotoxic conditioning regimens followed by infusion of hematopoietic stem cells. Although the outcomes have improved over the past decades, graft-versus-host-disease (GVHD), the most common life-threatening complication, remains a major cause of non-relapse morbidity and mortality. Pathophysiology of acute GVHD characterized by host antigen-presenting cells after tissue damage and donor T-cells is well studied, and additionally the importance of recipient microbiota in the intestine is elucidated in the GVHD setting. Oral microbiota is the second most abundant bacterial flora in the body after the intestinal tract, and it is related to chronic inflammation and carcinogenesis. Recently, composition of the oral microbiome in GVHD related to transplantation has been characterized and several common patterns, dysbiosis and enrichment of the specific bacterial groups, have been reported. This review focuses on the role of the oral microbiota in the context of GVHD.

3,445 views
2 citations
Recommended Research Topics
Frontiers Logo

Frontiers in Immunology

Cellular therapies: past, present and future
Edited by Hildegard Theresia Greinix, Ernst Holler, Ralf Dressel, Anne Mary Dickinson
115.4K
views
45
authors
9
articles
Frontiers Logo

Frontiers in Immunology

Non-Coding RNAs and Graft versus Host Disease
Edited by Pavan Reddy, Robert Zeiser
20.1K
views
24
authors
6
articles
Frontiers Logo

Frontiers in Immunology

Pathogenesis and Therapy of Graft-versus-Host Disease
Edited by Xue-Zhong Yu, Brian Christopher Betts
97.4K
views
101
authors
17
articles
Frontiers Logo

Frontiers in Immunology

Immune Aging: Implications for Transplantation
Edited by John R Greenland, Stefan Guenther Tullius, Joanna M. Schaenman
31.3K
views
55
authors
9
articles
Frontiers Logo

Frontiers in Immunology

Novel and improved methods for the prevention and treatment of Graft-Versus-Host Disease (GVHD)
Edited by Dietlinde Wolf, Evelyn Ullrich, Andreas Beilhack
70.1K
views
97
authors
13
articles